Tyler Golato
Co-Initiator at BIO Protocol · Co-Founder at Molecule · Partner at Triplicate · Co-Initiator at VitaDAO
Tyler Golato is a partner at Triplicate and co-founder of Molecule, an open-source protocol for drug development. Previously, he worked at the National Institute of Aging Research (NIH/NIA/IRP) under the guidance of Dr. David M. Wilson III and Dr. Vilhelm Bohr, focusing on repairing endogenous DNA damage, especially in the context of aging. Additionally, Tyler co-founded VitaDAO and bio.xyz. Before working in DeSci, Tyler had an accomplished early career as a biochemist, molecular biologist and biogerontologist.
Current Roles
Investments
News Mentions
Friedberg: New study shows enzyme reverses skin age from 70+ years to 31 Chamath: That’s a $2T market. Did Scientists Just Discover How to Reverse Skin Aging!? “CML is kind of the predominant molecule that gets formed in this extracellular matrix that's driving aging, and nothing breaks it down.
A sugar molecule has been found in space for the first time ever Researchers say it opens "the possibility for life to develop elsewhere in the universe"
RT @vitadao: Welcoming Michael Torres, Ph.D. (@Mykalt45) as a Core Advisor to VitaDAO. From lab bench → clinic → a ~$300M Eli Lilly acquis…
Hello, my dear friends, we have some breaking news today! Our rentosertib (novel target that has never been in clinical trials before we picked it using AI, novel molecule designed using true generative AI with the published broadly used AI platform, targeting fibrosis and biology of aging) entered
Bio Protocol develops AI agents to enhance decentralized science operations
RT @DeSciBerlin: Ben Snipes, Chief Legal Officer @Molecule_sci opens Day 2 of DeSci Berlin! How does it work when token holders can also b…
Highly recommend watching this for an up to date view of all things DeSci Incredible speakers, updates on AI efforts, and real world asset tokenisation happening https://x.com/bioprotocol/status/2067517614210130404
GPT-5.4 reviewed scientific literature, generated and ranked research proposals, helped design experiments, analyzed results, and proposed follow-up studies. Human chemists steered the work, selected proposals for testing, and validated the final result.
RT @DeSciBerlin: "The Compliant Path from Community to Cap Table" Ben, Chief Legal Officer at @Molecule_sci, on how token holders can foll…
Multiple Tokens Deployed on Base by @basemateagent and @goremyai